Private Equity

A landmark lawsuit claims the city’s failure to regulate vendors has decimated a community market, threatening student scholarships and small businesses.

Investors eye Hexcel's Q4 2025 results for signs of an aerospace rebound, strategic shifts under new leadership, and the future of advanced composites.

StickIt Technologies bets on a complex share consolidation and capital raise to survive, but are the terms a red flag for its investors and future?

The cruise retailer resumes dividends after a multi-year pause and buys back shares from its founding family, signaling deep confidence in its future.

HVAC/R giant Watsco extends its 52-year dividend streak, signaling robust financial health and a strategy built on market consolidation and AI.

ORIX restructures its global operations, tapping Terry Suzuki to lead a new USA & Europe unit aimed at accelerating its 2035 vision and asset growth.

Tire giant Michelin buys advanced materials firm Tex-Tech to fuel its diversification, as a new defense-focused composite entity, FMI, is spun off.

Fresh off a major drug approval, Insmed's upcoming J.P. Morgan talk is under scrutiny as investors eye pipeline updates and acquisition potential.

Nouveau Monde Graphite issues stock to pay interest to its major investor, Investissement Québec, highlighting a strategy to conserve cash for key projects.

Cannara Biotech rockets to #1 in Québec's cannabis market, fueled by a smash-hit vape launch, while also moving to overhaul its corporate governance.

Following the sale of its legacy business, the newly-rebranded Accendra Health launches on the NYSE with a laser focus on the booming home healthcare market.

The strategic separation of MarathonLS into two specialized firms aims to boost growth and service in the competitive life sciences support sector.

As INCERGO finalizes its Visual Semiconductor merger, it's betting on GF3D™ tech to revive 3D displays. Can it succeed where 3D TVs failed?

Neovii Pharmaceuticals names Frédéric Prince its next CEO, bringing deep oncology and gene therapy experience from Roche to steer its next growth phase.

Distressed debt giant Silver Point Capital acquires a controlling interest in claims against bankrupt auto parts maker First Brands, a strategic move.

The MICE giant's massive government contract to manage a 185,000-pilgrim yatra signals a strategic shift and a new model for public-private partnerships.

World No.1 table tennis star Sun Yingsha joins La Roche-Posay in a strategic play for Gen-Z hearts and the massive Asian beauty market.

With a 79% drop in net loss and a fourth straight growth quarter, supplement maker Vitality Products Inc. bets on new hires to conquer online and retail.

Vivakor blames a government shutdown for its dividend delay, but shareholders are left grappling with an unusual asset and a complex CEO-related deal.

All eyes are on Sandisk's Jan 29 report. Can the reborn flash memory leader meet lofty expectations and prove its post-spin-off strategy is a success?